This afternoon at our GHRU AGM, we’re diving into challenges and opportunities of structured surveys through a World Café format.
From communicating results beyond journals to measuring impact, colleagues from across the GHRU network are exchanging insights and solutions that will make a valuable contribution to our future work.
We’re in the Philippines 🇵🇭 this week for the 6th NIHR Global Health Research Unit Annual Meeting on Genomic Surveillance of AMR.
Hosted by our partners at @RITMPH, teams from across the GHRU network are sharing progress and planning for the future.
Kicking off Day 2 of #GHRU2025 in Bohol 🇵🇭 with a focus on structured surveys.
Our @NIHRresearch-funded Global Health Research Unit teams are sharing updates on the KlebSurvey and developing rapid reports to support public health decision-making.
Our @NIHRresearch funded GHRU together in Bohol, Philippines.
Colleagues from Colombia, India, Nigeria, the Philippines & the UK working together to strengthen genomic surveillance of AMR at the Unit’s annual general meeting. 🌍🤝🧬
Pleased to share our new preprint describing vaccines.watch, an interactive platform enabling exploration of vaccine target diversity from global genome data: biorxiv.org/content/10.1101/…
vaccines.watch currently displays data for >100k high-quality genomes with geotemporal sampling information (post-2010), but we demonstrate that substantial biases and geographic gaps remain in the coverage of available genomes.
We’re pleased to share two new preprints with results from a structured survey of carbapenem- and/or colistin-resistant Enterobacterales (CCRE), conducted in 37 European countries in 2019.
E. coli: papers.ssrn.com/sol3/papers.…
K. pneumoniae: papers.ssrn.com/sol3/papers.…
@ECDC_EU
Our findings suggest that the situation with carbapenem-resistant K. pneumoniae has continued to worsen and that control measures have not been able to interrupt transmission of high-risk lineages circulating within European hospital networks.
Our latest preprint is out describing amr.watch – a platform for monitoring AMR trends from global genomics data. Supporting all WHO priority pathogens (2017), amr.watch summarises the geographic and temporal distribution of genotypic variants (e.g. STs) in the context of AMR to aid monitoring and prioritisation efforts. biorxiv.org/content/10.1101/…
Always-on: all QC’d genomes with geotemporal metadata, are ingested from archives, analysed in pathogen.watch and results visualised within amr.watch. Data are extracted and updated every 4h, with observed trends therefore only delayed by time to genome deposition. See more on filtering here : amr.watch/summary
Huge disparity in genomic data: We support all efforts to increase the genomic surveillance of pathogens on a global scale as dynamics differ locally: what happens in one place does not translate to another and high-risk clones can emerge anywhere. amr.watch can be used to assess the representation of geographic regions, e.g. with countries here in white currently lacking any public genomes. See more at: amr.watch/all




















